In Brief
Caps trade margins on 137 anti-cancer formulations at 30% to regulate pricing and ease healthcare costs.
The Central Government has imposed a 30% cap on trade margins for 137 anti-cancer medicines. The measure aims to curb excessive markups across retail and institutional supply chains, directly lowering the out-of-pocket costs of critical oncology treatments.
Railways to turn off train charging points at night to stop fires
29 Oct 2026
Indian Railways Extends 45-Paise Travel Insurance to Counter Tickets
26 Oct 2026
Digital Agriculture Push: 11 Crore Farmers Issued Unique Identification IDs
25 Oct 2026
Kerala Sanctions ₹1,081 Crore for Social Security and Welfare Board Pensions
25 Oct 2026